| [1] |
Berman B, Maderal A, Raphael B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment[J]. Dermatol Surg, 2017, 43 Suppl 1: S3-S18.
|
| [2] |
Zhang C, Chen Y, Fu X. Sweat gland regeneration after burn injury: is stem cell therapy a new hope？[J]. Cytotherapy, 2015, 17(5): 526-535.
|
| [3] |
Li Q, Zhang C, Fu X. Will stem cells bring hope to pathological skin scar treatment？[J]. Cytotherapy, 2016, 18(8): 943-956.
|
| [4] |
Fu X, Li H. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions[J]. Cell Tissue Res, 2009, 335(2): 317-321.
|
| [5] |
Wang J, Liao L, Wang S, et al. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations[J]. Cytotherapy, 2013, 15(8): 893-904.
|
| [6] |
Ding L, Li X, Sun H, et al. Transplantation of bone marrow mesenchymal stem cells on collagen scaffolds for the functional regeneration of injured rat uterus[J]. Biomaterials, 2014, 35(18): 4888-4900.
|
| [7] |
Huang S, Wu Y, Gao D, et al. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice[J]. Cytotherapy, 2015, 17(7): 922-931.
|
| [8] |
Li Z, Wang H, Yang B, et al. Three-dimensional graphene foams loaded with bone marrow derived mesenchymal stem cells promote skin wound healing with reduced scarring[J]. Mater Sci Eng C Mater Biol Appl, 2015, 57: 181-188.
|
| [9] |
Jeong JH. Adipose stem cells and skin repair[J]. Curr Stem Cell Res Ther, 2010, 5(2): 137-140.
|
| [10] |
Liu J, Ren J, Su L, et al. Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling[J]. Burns, 2018, 44(2): 370-385.
|
| [11] |
Wang L, Hu L, Zhou X, et al. Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling[J]. Sci Rep, 2017, 7(1): 13321.
|
| [12] |
Zonari A, Martins TM, Paula AC, et al. Polyhydroxybutyrate-co-hydroxyvalerate structures loaded with adipose stem cells promote skin healing with reduced scarring[J]. Acta Biomater, 2015, 17: 170-181.
|
| [13] |
Kocaefe C, Balci D, Hayta BB, et al. Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair[J]. Stem Cell Rev Rep, 2010, 6(4): 512-522.
|
| [14] |
Peng J, Wang Y, Zhang L, et al. Human umbilical cord Wharton′s jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro[J]. Brain Res Bull, 2011, 84(3): 235-243.
|
| [15] |
Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton′s jelly of the human umbilical cord[J]. Stem Cell Rev Rep, 2013, 9(2): 226-240.
|
| [16] |
Anzalone R, Lo Iacono M, Corrao S, et al. New emerging potentials for human Wharton′s jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity[J]. Stem Cells Dev, 2010, 19(4): 423-438.
|
| [17] |
Nekanti U, Rao VB, Bahirvani AG, et al. Long-term expansion and pluripotent marker array analysis of Wharton′s jelly-derived mesenchymal stem cells[J]. Stem Cells Dev, 2010, 19(1): 117-130.
|
| [18] |
Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord[J]. Stem Cell Rev Rep, 2011, 7(1): 195-207.
|
| [19] |
Batsali AK, Pontikoglou C, Koutroulakis D, et al. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton′s jelly and bone marrow-derived mesenchymal stem cells[J]. Stem Cell Res Ther, 2017, 8(1): 102.
|
| [20] |
Himal I, Goyal U, Ta M. Evaluating Wharton′s Jelly-Derived Mesenchymal Stem Cell′s Survival, Migration, and Expression of Wound Repair Markers under Conditions of Ischemia-Like Stress[J]. Stem Cells Int, 2017, 2017: 5259849.
|
| [21] |
Bakhtyar N, Jeschke MG, Herer E, et al. Exosomes from acellular Wharton′s jelly of the human umbilical cord promotes skin wound healing[J]. Stem Cell Res Ther, 2018, 9(1): 193.
|
| [22] |
Zheng Y, Zheng S, Fan X, et al. Amniotic Epithelial Cells Accelerate Diabetic Wound Healing by Modulating Inflammation and Promoting Neovascularization[J]. Stem Cells Int, 2018, 2018: 1082076.
|
| [23] |
Zhao B, Zhang Y, Han S, et al. Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation[J]. J Mol Histol, 2017, 48(2): 121-132.
|
| [24] |
Zhao B, Liu JQ, Yang C, et al. Human amniotic epithelial cells attenuate TGF-β1-induced human dermal fibroblast transformation to myofibroblasts via TGF-β1/Smad3 pathway[J]. Cytotherapy, 2016, 18(8): 1012-1024.
|
| [25] |
Troy TC, Turksen K. Using high-throughput immunoblotting to identify proteins involved in the differentiation of ES cells along the hair follicle lineage in vitro[J]. Stem Cell Rev Rep, 2011, 7(4): 1041-1045.
|
| [26] |
Dreymueller D, Denecke B, Ludwig A, et al. Embryonic stem cell-derived M2-like macrophages delay cutaneous wound healing[J]. Wound Repair Regen, 2013, 21(1): 44-54.
|
| [27] |
Liu SP, Fu RH, Huang YC, et al. Induced pluripotent stem (iPS) cell research overview[J]. Cell Transplant, 2011, 20(1): 15-19.
|
| [28] |
Ren Y, Deng CL, Wan WD, et al. Suppressive effects of induced pluripotent stem cell-conditioned medium on in vitro hypertrophic scarring fibroblast activation[J]. Mol Med Rep, 2015, 11(4): 2471-2476.
|
| [29] |
Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds[J]. Stem Cell Res Ther, 2010, 1(4): 30.
|